<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02693418</url>
  </required_header>
  <id_info>
    <org_study_id>EVO-002</org_study_id>
    <nct_id>NCT02693418</nct_id>
  </id_info>
  <brief_title>Duration of Effect of Acidform Gel on Vaginal pH</brief_title>
  <official_title>A Randomized, Placebo Controlled Pilot Study to Determine the Effect and Duration of Acidform Gel on Vaginal pH</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Evofem Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinical Research Management, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>MetroHealth Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Evofem Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study was to determine the magnitude and duration of the reduction in&#xD;
      pH (acidification) following a single dose of Acidform vaginal gel containing 3, 4, or 5 g&#xD;
      compared with hydroxyethylcellulose placebo gel (4 g) or no treatment. Vaginal pH was&#xD;
      measured 1 h, 6 h, 12 h, 24 h, then once daily for 7 days. In addition, the participants were&#xD;
      assessed for an exploratory endpoint to the determine effect of one dose of Acidform gel (3,&#xD;
      4 or 5 g) or placebo gel (4 g) or no treatment, on asymptomatic bacterial vaginosis (BV).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One hundred healthy volunteer women, 20 per each treatment arm, were treated with either&#xD;
      Intravaginal Acidform Gel(IVAG), 5 g dose (GROUP A), Acidform gel, 4 g dose (GROUP B),&#xD;
      Acidform gel, 3 g dose (GROUP C), Universal Placebo Gel (UPG), 4 g (GROUP D) or no treatment&#xD;
      (GROUP E). For GROUPS A, B, C and D, treatment is defined as speculum exam plus instillation&#xD;
      of Investigational Product (IP) or placebo gel. For GROUP E (control), no treatment is&#xD;
      defined as speculum exam and no gel instillation.&#xD;
&#xD;
      At least 15 women in each group were of either African American or Hispanic ethnicity.&#xD;
      Routine screening tests were performed on admission; and subjects assessed for BV via vaginal&#xD;
      swabs obtained for grading by Amsel criteria.&#xD;
&#xD;
      A direct vaginal pH reading by research staff- was obtained before the speculum exam, as well&#xD;
      as one hour, and six hours post-treatment (Day 0). At the one hour and six hour post&#xD;
      treatment time points, the direct vaginal pH readings were taken on specimens collected from&#xD;
      two different positions in the vagina, in case of incomplete distribution of the IP soon&#xD;
      after administration. Both readings are included as data points. At the six hour timepoint,&#xD;
      subjects were trained on self-collecting vaginal swabs and performing the vaginal pH test. At&#xD;
      12 hours post-treatment, subjects performed the vaginal pH test themselves using&#xD;
      self-obtained swabs, and record their results for clinician review.&#xD;
&#xD;
      Subjects stayed overnight in the domiciliary unit, and vaginal pH and Amsel criteria was&#xD;
      measured again by research staff at 24 (+/- 2) hours post-treatment before discharge on Day&#xD;
      1. The subjects were discharged with the appropriate pH testing supplies and diary. All women&#xD;
      agreed to abstain from sexual intercourse, douching and use of any intravaginally applied&#xD;
      products or devices until after their final study visit on Day 7.&#xD;
&#xD;
      Subjects measured their vaginal pH at 24 (+/-2) hour intervals for 5 days (Days 2-6) as&#xD;
      outpatients and recorded the pH test results, and any change in vaginal comfort, in a&#xD;
      provided diary. Subjects also recorded any activities engaged in from the abstinence criteria&#xD;
      in the study exclusion list, if applicable, each day. On Day 7, subjects returned to the&#xD;
      clinic with their diaries, had their vaginal pH and Amsel criteria determined by the clinic&#xD;
      staff, and queried as to any vaginal discomfort (vaginal comfort assessment) over the course&#xD;
      of the study, as self-recorded in their diaries.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 24, 2016</start_date>
  <completion_date type="Actual">December 12, 2016</completion_date>
  <primary_completion_date type="Actual">December 12, 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Vaginal pH Following a Single Dose of Acidform (3, 4, and 5 g), HEC Placebo (4 g), or no Intervention.</measure>
    <time_frame>Baseline (Day 0), 1, 6 &amp; 12 hours post treatment, and Days 1, 2, 3, 4, 5, 6 &amp; 7.</time_frame>
    <description>Vaginal swabs were used to collect samples from the vagina of women dosed with Acidform, HEC placebo, or no treatment. The pH of the samples was measured at pre-determined time points over the course of 7 days.</description>
  </primary_outcome>
  <other_outcome>
    <measure>The Effect of a Single Dose of Acidform Gel (3, 4 or 5 g), Placebo Gel (4 g), or no Treatment on Asymptomatic Bacterial Vaginosis (BV) Based on Amsel Criteria.</measure>
    <time_frame>Baseline (Day 0), Day 1 and Day 7</time_frame>
    <description>Amsel Criteria was used at baseline (day 0), compared to Day1 and Day 7 following the single dose of Acidform or placebo. Amsel criteria assessments consisted of Yes/No indications for the presence of each of the following: Vaginal pH&gt; 4.5; Presence of thin, grayish white vaginal discharge; Positive wet prep; Positive whiff amine test. Based on the individual criteria, a derived overall result (positive/negative) was reported. Amsel Result was automatically calculated based whether or not subject is positive in three of the four criteria listed above.</description>
  </other_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">105</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Acidform Gel, Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of a single vaginal dose of Acidform gel (5 g)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acidform Gel, Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of a single vaginal dose of Acidform gel (4 g)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acidform Gel, Group C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of a single vaginal dose of Acidform gel (3 g)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Gel, Group D</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administration of a single dose of hydroxyethylcellulose (HEC) placebo gel (4 g)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention, Group E</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No vaginal product administered</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acidform 5 g</intervention_name>
    <description>Effect of 5 g vaginally administered Acidform on pH over 7 days</description>
    <arm_group_label>Acidform Gel, Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo 4 g</intervention_name>
    <description>Effect of 4 g of vaginally administered HEC placebo gel on pH over 7 days</description>
    <arm_group_label>Placebo Gel, Group D</arm_group_label>
    <other_name>Natrasol 250 HX Pharm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acidform 4 g</intervention_name>
    <description>Effect of 4 g vaginally administered Acidform on pH over 7 days</description>
    <arm_group_label>Acidform Gel, Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acidform 3 g</intervention_name>
    <description>Effect of 3 g vaginally administered Acidform on pH over 7 days</description>
    <arm_group_label>Acidform Gel, Group C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Healthy female subjects between 18 and 45 years, inclusive&#xD;
&#xD;
          2. Ability to understand the consent process and procedures&#xD;
&#xD;
          3. Subjects agree to be available for all study visits&#xD;
&#xD;
          4. Written informed consent in accordance with institutional guidelines&#xD;
&#xD;
          5. Negative pregnancy test&#xD;
&#xD;
          6. Able and willing to comply with all study procedures&#xD;
&#xD;
          7. Have not engaged in sexual intercourse, douching or used of any form of vaginal&#xD;
             suppository or intravaginal device for 24 hours prior to enrollment.&#xD;
&#xD;
          8. Agree to abstain from sexual intercourse, douching or any form of vaginal suppository&#xD;
             or intravaginal device use during course of study&#xD;
&#xD;
          9. Report menstrual cycle regularity (25- to 35- day menstrual cycles)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Participation in any study with an investigational compound or device within 30 days&#xD;
             prior to signing informed consent&#xD;
&#xD;
          2. Active drug or alcohol use or dependence that, in the opinion of the investigator,&#xD;
             would interfere with adherence to study protocol&#xD;
&#xD;
          3. Any other medical condition(s) that, in the judgment of the investigator, might&#xD;
             interfere with the study or require treatment that might interfere with the study&#xD;
&#xD;
          4. Family member of the investigation study staff&#xD;
&#xD;
          5. Pregnant or breast-feeding&#xD;
&#xD;
          6. Inability to provide informed consent&#xD;
&#xD;
          7. A subject with a history or expectation of noncompliance with medications or treatment&#xD;
             protocol&#xD;
&#xD;
          8. Women with symptoms of Urinary Tract Infection (UTI) or Sexually Transmitted Infection&#xD;
             (STI) reported or observed during examination, at screening*.&#xD;
&#xD;
          9. Women who regularly use douches, vaginal medications or suppositories, feminine&#xD;
             sprays, genital wipes or contraceptive spermicides, or report abnormal vaginal&#xD;
             discharge in the past 48 hours prior to screening&#xD;
&#xD;
         10. Women who are menstruating or who would expect to menstruate during the study&#xD;
&#xD;
         11. Women who are currently using contraceptives that are directly delivered to the&#xD;
             vaginal mucosa, such as NuvaRing&#xD;
&#xD;
         12. Any specific condition that, in the judgment of the Investigator, precludes&#xD;
             participation because it could affect subject safety&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ann Avery, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Metro Health Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seema Nayak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John M Griffiss, MD</last_name>
    <role>Study Director</role>
    <affiliation>Clinical Research Management, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins Bayview Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metro Health Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>February 18, 2016</study_first_submitted>
  <study_first_submitted_qc>February 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2016</study_first_posted>
  <results_first_submitted>September 26, 2020</results_first_submitted>
  <results_first_submitted_qc>October 29, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 20, 2020</results_first_posted>
  <last_update_submitted>October 29, 2020</last_update_submitted>
  <last_update_submitted_qc>October 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Acidform Gel, Group A</title>
          <description>Administration of a single vaginal dose of Acidform gel (5 g)&#xD;
Acidform 5 g: Effect of 5 g vaginally administered Acidform on pH over 7 days</description>
        </group>
        <group group_id="P2">
          <title>Acidform Gel, Group B</title>
          <description>Administration of a single vaginal dose of Acidform gel (4 g)&#xD;
Acidform 4 g: Effect of 4 g vaginally administered Acidform on pH over 7 days</description>
        </group>
        <group group_id="P3">
          <title>Acidform Gel, Group C</title>
          <description>Administration of a single vaginal dose of Acidform gel (3 g)&#xD;
Acidform 3 g: Effect of 3 g vaginally administered Acidform on pH over 7 days</description>
        </group>
        <group group_id="P4">
          <title>Placebo Gel, Group D</title>
          <description>Administration of a single dose of hydroxyethylcellulose (HEC) placebo gel (4 g)&#xD;
Placebo 4 g: Effect of 4 g of vaginally administered HEC placebo gel on pH over 7 days</description>
        </group>
        <group group_id="P5">
          <title>No Intervention, Group E</title>
          <description>No vaginal product administered</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="21"/>
                <participants group_id="P3" count="21"/>
                <participants group_id="P4" count="20"/>
                <participants group_id="P5" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="19"/>
                <participants group_id="P3" count="19"/>
                <participants group_id="P4" count="20"/>
                <participants group_id="P5" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Menses during study period</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Safety population</population>
      <group_list>
        <group group_id="B1">
          <title>Acidform Gel, Group A</title>
          <description>Administration of a single vaginal dose of Acidform gel (5 g)&#xD;
Acidform 5 g: Effect of 5 g vaginally administered Acidform on pH over 7 days</description>
        </group>
        <group group_id="B2">
          <title>Acidform Gel, Group B</title>
          <description>Administration of a single vaginal dose of Acidform gel (4 g)&#xD;
Acidform 4 g: Effect of 4 g vaginally administered Acidform on pH over 7 days</description>
        </group>
        <group group_id="B3">
          <title>Acidform Gel, Group C</title>
          <description>Administration of a single vaginal dose of Acidform gel (3 g)&#xD;
Acidform 3 g: Effect of 3 g vaginally administered Acidform on pH over 7 days</description>
        </group>
        <group group_id="B4">
          <title>Placebo Gel, Group D</title>
          <description>Administration of a single dose of hydroxyethylcellulose (HEC) placebo gel (4 g)&#xD;
Placebo 4 g: Effect of 4 g of vaginally administered HEC placebo gel on pH over 7 days</description>
        </group>
        <group group_id="B5">
          <title>No Intervention, Group E</title>
          <description>No vaginal product administered</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="21"/>
            <count group_id="B3" value="21"/>
            <count group_id="B4" value="20"/>
            <count group_id="B5" value="21"/>
            <count group_id="B6" value="105"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="21"/>
                    <count group_id="B3" value="21"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="21"/>
                    <count group_id="B6" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.62" spread="7.11"/>
                    <measurement group_id="B2" value="28.57" spread="7.20"/>
                    <measurement group_id="B3" value="28.12" spread="5.40"/>
                    <measurement group_id="B4" value="30.42" spread="6.47"/>
                    <measurement group_id="B5" value="30.21" spread="6.45"/>
                    <measurement group_id="B6" value="29.8" spread="6.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="21"/>
                    <count group_id="B3" value="21"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="21"/>
                    <count group_id="B6" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="21"/>
                    <measurement group_id="B6" value="105"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="21"/>
                    <count group_id="B3" value="21"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="21"/>
                    <count group_id="B6" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="18"/>
                    <measurement group_id="B6" value="82"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="21"/>
                    <count group_id="B3" value="21"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="21"/>
                    <count group_id="B6" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="12"/>
                    <measurement group_id="B6" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="7"/>
                    <measurement group_id="B6" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <population>One subject in the IVAG acid form 3g group had missing weight data.</population>
          <units>pounds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="21"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="21"/>
                    <count group_id="B6" value="104"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="169.54" spread="49.56"/>
                    <measurement group_id="B2" value="169.85" spread="41.48"/>
                    <measurement group_id="B3" value="183.81" spread="52.97"/>
                    <measurement group_id="B4" value="171.40" spread="42.27"/>
                    <measurement group_id="B5" value="177.09" spread="48.91"/>
                    <measurement group_id="B6" value="174.23" spread="46.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <population>One subject in the IVAG acid form 3g group had missing height data</population>
          <units>Inches</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="21"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="21"/>
                    <count group_id="B6" value="104"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.19" spread="2.55"/>
                    <measurement group_id="B2" value="64.62" spread="2.27"/>
                    <measurement group_id="B3" value="63.74" spread="2.89"/>
                    <measurement group_id="B4" value="63.91" spread="2.47"/>
                    <measurement group_id="B5" value="64.77" spread="2.62"/>
                    <measurement group_id="B6" value="64.46" spread="2.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <population>One subject in the IVAG acid form 3g group did not have BMI data</population>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="21"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="21"/>
                    <count group_id="B6" value="104"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.02" spread="7.55"/>
                    <measurement group_id="B2" value="28.59" spread="6.69"/>
                    <measurement group_id="B3" value="31.87" spread="9.30"/>
                    <measurement group_id="B4" value="29.84" spread="8.51"/>
                    <measurement group_id="B5" value="29.55" spread="7.13"/>
                    <measurement group_id="B6" value="29.53" spread="7.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Vaginal pH Following a Single Dose of Acidform (3, 4, and 5 g), HEC Placebo (4 g), or no Intervention.</title>
        <description>Vaginal swabs were used to collect samples from the vagina of women dosed with Acidform, HEC placebo, or no treatment. The pH of the samples was measured at pre-determined time points over the course of 7 days.</description>
        <time_frame>Baseline (Day 0), 1, 6 &amp; 12 hours post treatment, and Days 1, 2, 3, 4, 5, 6 &amp; 7.</time_frame>
        <population>Summary of Changes from Baseline (baseline value for vaginal pH is the Pre-Dose measurement on Day 0). Vaginal pH was obtained by the subject on Day 0 (12 hours post treatment only), Day 2, Day 3, Day 4, Day 5 and Day 6. All other vaginal pH values were obtained by the Research staff.</population>
        <group_list>
          <group group_id="O1">
            <title>Acidform Gel, Group A</title>
            <description>Administration of a single vaginal dose of Acidform gel (5 g)&#xD;
Acidform 5 g: Effect of 5 g vaginally administered Acidform on pH over 7 days</description>
          </group>
          <group group_id="O2">
            <title>Acidform Gel, Group B</title>
            <description>Administration of a single vaginal dose of Acidform gel (4 g)&#xD;
Acidform 4 g: Effect of 4 g vaginally administered Acidform on pH over 7 days</description>
          </group>
          <group group_id="O3">
            <title>Acidform Gel, Group C</title>
            <description>Administration of a single vaginal dose of Acidform gel (3 g)&#xD;
Acidform 3 g: Effect of 3 g vaginally administered Acidform on pH over 7 days</description>
          </group>
          <group group_id="O4">
            <title>Placebo Gel, Group D</title>
            <description>Administration of a single dose of hydroxyethylcellulose (HEC) placebo gel (4 g)&#xD;
Placebo 4 g: Effect of 4 g of vaginally administered HEC placebo gel on pH over 7 days</description>
          </group>
          <group group_id="O5">
            <title>No Intervention, Group E</title>
            <description>No vaginal product administered</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Vaginal pH Following a Single Dose of Acidform (3, 4, and 5 g), HEC Placebo (4 g), or no Intervention.</title>
          <description>Vaginal swabs were used to collect samples from the vagina of women dosed with Acidform, HEC placebo, or no treatment. The pH of the samples was measured at pre-determined time points over the course of 7 days.</description>
          <population>Summary of Changes from Baseline (baseline value for vaginal pH is the Pre-Dose measurement on Day 0). Vaginal pH was obtained by the subject on Day 0 (12 hours post treatment only), Day 2, Day 3, Day 4, Day 5 and Day 6. All other vaginal pH values were obtained by the Research staff.</population>
          <units>pH</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline measure (Day 0)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.85" spread="0.55"/>
                    <measurement group_id="O2" value="4.81" spread="0.62"/>
                    <measurement group_id="O3" value="4.91" spread="0.57"/>
                    <measurement group_id="O4" value="5.00" spread=".069"/>
                    <measurement group_id="O5" value="4.77" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour Post-Tx Summary of Changes from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.44" spread="0.50"/>
                    <measurement group_id="O2" value="-0.19" spread="0.54"/>
                    <measurement group_id="O3" value="-0.30" spread="0.66"/>
                    <measurement group_id="O4" value="-.031" spread="0.55"/>
                    <measurement group_id="O5" value="-0.16" spread="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hour Post-Tx Summary of Changes from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.59" spread="0.50"/>
                    <measurement group_id="O2" value="-0.51" spread="0.57"/>
                    <measurement group_id="O3" value="-0.49" spread="0.47"/>
                    <measurement group_id="O4" value="-0.16" spread="0.53"/>
                    <measurement group_id="O5" value="-0.02" spread="0.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hour Post-tx Summary Changes from baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.76" spread="0.57"/>
                    <measurement group_id="O2" value="-0.72" spread="0.57"/>
                    <measurement group_id="O3" value="-0.58" spread="0.70"/>
                    <measurement group_id="O4" value="-0.02" spread="0.55"/>
                    <measurement group_id="O5" value="0.01" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1 Summary of Changes from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.72" spread="0.55"/>
                    <measurement group_id="O2" value="-0.50" spread="0.54"/>
                    <measurement group_id="O3" value="-0.29" spread="0.65"/>
                    <measurement group_id="O4" value="-0.13" spread="0.35"/>
                    <measurement group_id="O5" value="0.19" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2 Summary of Changes from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="19"/>
                    <count group_id="O3" value="20"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.33" spread="0.42"/>
                    <measurement group_id="O2" value="-0.43" spread="0.42"/>
                    <measurement group_id="O3" value="-0.25" spread="0.39"/>
                    <measurement group_id="O4" value="0.23" spread="0.65"/>
                    <measurement group_id="O5" value="-0.01" spread="0.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3 Summary of Changes from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="19"/>
                    <count group_id="O3" value="20"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.40" spread="0.43"/>
                    <measurement group_id="O2" value="-0.34" spread="0.56"/>
                    <measurement group_id="O3" value="-0.10" spread="0.50"/>
                    <measurement group_id="O4" value="0.05" spread="0.64"/>
                    <measurement group_id="O5" value="0.04" spread="0.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4 Summary of Changes from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="19"/>
                    <count group_id="O3" value="20"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.38" spread="0.46"/>
                    <measurement group_id="O2" value="-0.34" spread="0.39"/>
                    <measurement group_id="O3" value="-0.22" spread="0.47"/>
                    <measurement group_id="O4" value="0.11" spread="0.68"/>
                    <measurement group_id="O5" value="0.06" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5 Summary of Changes from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="19"/>
                    <count group_id="O3" value="20"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.36" spread="0.44"/>
                    <measurement group_id="O2" value="-0.24" spread="0.52"/>
                    <measurement group_id="O3" value="-0.25" spread="0.36"/>
                    <measurement group_id="O4" value="-0.25" spread="0.43"/>
                    <measurement group_id="O5" value="0.09" spread="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 6 Summary of Changes from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="19"/>
                    <count group_id="O3" value="17"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.46" spread="0.51"/>
                    <measurement group_id="O2" value="-0.18" spread="0.77"/>
                    <measurement group_id="O3" value="-0.24" spread="0.49"/>
                    <measurement group_id="O4" value="-0.19" spread="0.47"/>
                    <measurement group_id="O5" value="-0.01" spread="0.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7 Summary of Changes from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="19"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="0.50"/>
                    <measurement group_id="O2" value="-0.16" spread="0.48"/>
                    <measurement group_id="O3" value="-0.19" spread="0.48"/>
                    <measurement group_id="O4" value="-0.16" spread="0.64"/>
                    <measurement group_id="O5" value="-0.06" spread="0.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>The Effect of a Single Dose of Acidform Gel (3, 4 or 5 g), Placebo Gel (4 g), or no Treatment on Asymptomatic Bacterial Vaginosis (BV) Based on Amsel Criteria.</title>
        <description>Amsel Criteria was used at baseline (day 0), compared to Day1 and Day 7 following the single dose of Acidform or placebo. Amsel criteria assessments consisted of Yes/No indications for the presence of each of the following: Vaginal pH&gt; 4.5; Presence of thin, grayish white vaginal discharge; Positive wet prep; Positive whiff amine test. Based on the individual criteria, a derived overall result (positive/negative) was reported. Amsel Result was automatically calculated based whether or not subject is positive in three of the four criteria listed above.</description>
        <time_frame>Baseline (Day 0), Day 1 and Day 7</time_frame>
        <population>Day 0 (Baseline), Day 1 and Day 7, Amsel Tests Overall results</population>
        <group_list>
          <group group_id="O1">
            <title>Acidform Gel, Group A</title>
            <description>Administration of a single vaginal dose of Acidform gel (5 g)&#xD;
Acidform 5 g: Effect of 5 g vaginally administered Acidform on pH over 7 days</description>
          </group>
          <group group_id="O2">
            <title>Acidform Gel, Group B</title>
            <description>Administration of a single vaginal dose of Acidform gel (4 g)&#xD;
Acidform 4 g: Effect of 4 g vaginally administered Acidform on pH over 7 days</description>
          </group>
          <group group_id="O3">
            <title>Acidform Gel, Group C</title>
            <description>Administration of a single vaginal dose of Acidform gel (3 g)&#xD;
Acidform 3 g: Effect of 3 g vaginally administered Acidform on pH over 7 days</description>
          </group>
          <group group_id="O4">
            <title>Placebo Gel, Group D</title>
            <description>Administration of a single dose of hydroxyethylcellulose (HEC) placebo gel (4 g)&#xD;
Placebo 4 g: Effect of 4 g of vaginally administered HEC placebo gel on pH over 7 days</description>
          </group>
          <group group_id="O5">
            <title>No Intervention, Group E</title>
            <description>No vaginal product administered</description>
          </group>
        </group_list>
        <measure>
          <title>The Effect of a Single Dose of Acidform Gel (3, 4 or 5 g), Placebo Gel (4 g), or no Treatment on Asymptomatic Bacterial Vaginosis (BV) Based on Amsel Criteria.</title>
          <description>Amsel Criteria was used at baseline (day 0), compared to Day1 and Day 7 following the single dose of Acidform or placebo. Amsel criteria assessments consisted of Yes/No indications for the presence of each of the following: Vaginal pH&gt; 4.5; Presence of thin, grayish white vaginal discharge; Positive wet prep; Positive whiff amine test. Based on the individual criteria, a derived overall result (positive/negative) was reported. Amsel Result was automatically calculated based whether or not subject is positive in three of the four criteria listed above.</description>
          <population>Day 0 (Baseline), Day 1 and Day 7, Amsel Tests Overall results</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline Day 0 Positive</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline Day 0 Negative</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="20"/>
                    <measurement group_id="O4" value="16"/>
                    <measurement group_id="O5" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1 Positive</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="20"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1 Negative</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="20"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="18"/>
                    <measurement group_id="O5" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7 Positive</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="18"/>
                    <count group_id="O3" value="17"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7 Negative</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="18"/>
                    <count group_id="O3" value="17"/>
                    <count group_id="O4" value="20"/>
                    <count group_id="O5" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="18"/>
                    <measurement group_id="O5" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>7 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Acidform Gel, Group A</title>
          <description>Administration of a single vaginal dose of Acidform gel (5 g)&#xD;
Acidform 5 g: Effect of 5 g vaginally administered Acidform on pH over 7 days</description>
        </group>
        <group group_id="E2">
          <title>Acidform Gel, Group B</title>
          <description>Administration of a single vaginal dose of Acidform gel (4 g)&#xD;
Acidform 4 g: Effect of 4 g vaginally administered Acidform on pH over 7 days</description>
        </group>
        <group group_id="E3">
          <title>Acidform Gel, Group C</title>
          <description>Administration of a single vaginal dose of Acidform gel (3 g)&#xD;
Acidform 3 g: Effect of 3 g vaginally administered Acidform on pH over 7 days</description>
        </group>
        <group group_id="E4">
          <title>Placebo Gel, Group D</title>
          <description>Administration of a single dose of hydroxyethylcellulose (HEC) placebo gel (4 g)&#xD;
Placebo 4 g: Effect of 4 g of vaginally administered HEC placebo gel on pH over 7 days</description>
        </group>
        <group group_id="E5">
          <title>No Intervention, Group E</title>
          <description>No vaginal product administered</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (17.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="21"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="21"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="20"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Muscle Spasms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Micturition urgency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Cervical discharge</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Cervix disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Cervix inflamation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Menstruation irregular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Vaginal discharge</sub_title>
                <counts group_id="E1" events="19" subjects_affected="15" subjects_at_risk="22"/>
                <counts group_id="E2" events="19" subjects_affected="13" subjects_at_risk="21"/>
                <counts group_id="E3" events="18" subjects_affected="12" subjects_at_risk="21"/>
                <counts group_id="E4" events="14" subjects_affected="10" subjects_at_risk="20"/>
                <counts group_id="E5" events="4" subjects_affected="3" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Vaginal odour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Vulvovaginal burning sensation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Vulvovaginal discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Vulvovaginal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Vulvovaginal pruritus</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Low number of subjects at each time point and lost specimens meant a complete analyses were not conducted on specimens from all subjects at all time points and further studies are required to confirm these findings.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Kelly Culwell, MD, MPH, FACOG</name_or_title>
      <organization>Evofem Biosciences</organization>
      <phone>858-550-1900 ext 225</phone>
      <email>kculwell@evofem.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

